Author information

¹Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

²Internal Medicine, Medical College Baroda, Vadodara, IND.

³Medicine, Kakatiya Medical College, Hyderabad, IND.

⁴Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

⁵Medicine, Osmania Medical College, Hyderabad, IND.

⁶General Practice, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

⁷Pathology and Laboratory Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

⁸Surgical Oncology, Tata Medical Centre, Kolkata, IND.

⁹Surgical Oncology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Abstract

Transarterial chemoembolization (TACE) is considered the preferred loco-regional treatment option for hepatocellular carcinoma (HCC) not amenable to resection due to its distinctive blend of precise drug administration, localized tumor management, and reduced systemic adverse effects, setting it apart from the plethora of alternative treatments available. There is an ongoing debate regarding the optimal choice for managing HCC using TACE, particularly between its two major types: conventional TACE (cTACE) and drug-eluting bead TACE (DEB-TACE). The medical community remains divided on which approach offers superior safety and efficacy, with conflicting evidence and varied outcomes adding to the complexity of this nuanced decision. Given the lack of consensus surrounding the preferred TACE technique in treatment-naive patients for HCC, we conducted a rigorous systematic review to assess and contrast the relative safety and efficacy of cTACE versus DEB-TACE in patients diagnosed with HCC who did not receive any prior treatment for HCC. Our study aimed to provide much-needed clarity on this controversial topic, shedding light on the two approaches' comparative safety and efficacy to inform clinical decision-making. After a comprehensive search of databases and search engines and through a methodical screening process, including standardized quality assessments and relevant filter application based on our eligibility criteria, we identified 10 articles pertinent to our research query comprising two randomized controlled trials, one meta-analysis, and seven observational studies. The collective sample size of the studies was 5,288 patients with HCC, of which 2,959 were in the cTACE arm and 2,324 were in the DEB-TACE arm.